Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
Niko Kohmer, Holger F. Rabenau, Sebastian Hoehl, Marhild Kortenbusch, Sandra Ciesek, Annemarie Berger
Topics & Concepts
NatSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPoint-of-care testingPrimer (cosmetics)Nucleic Acid Amplification TestsExternal quality assessmentNucleic acid testPoint of careBiologyMolecular diagnosticsCoronavirus disease 2019 (COVID-19)Molecular biologyMedicineImmunologyChemistryInfectious disease (medical specialty)PathologyBioinformaticsDiseaseComputer scienceChlamydia trachomatisComputer networkOrganic chemistrySARS-CoV-2 detection and testingBiosensors and Analytical DetectionSARS-CoV-2 and COVID-19 Research